Skip to main content
TipRanks
Go Ultimate75% OFF

Concord Biotech Ltd. (CONCORDBIO) Income Statement

4 Followers

Concord Biotech Ltd. Income Statement

Last quarter (Q2 2027), Concord Biotech Ltd.'s total revenue was ₹3.09B, an increase of 25.10% from the same quarter last year. In Q2, Concord Biotech Ltd.'s net income was ₹706.53M. See Concord Biotech Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 26Mar 25Mar 24Mar 23Mar 22
₹ 10.55B₹ 12.00B₹ 10.17B₹ 8.53B₹ 7.13B
₹ 4.42B₹ 7.68B₹ 6.67B₹ 6.61B₹ 5.41B
₹ 1.49B₹ 1.66B₹ 1.46B₹ 1.43B₹ 1.25B
Depreciation and Amortization₹ 744.59M₹ 543.74M₹ 535.91M₹ 540.32M₹ 500.50M
₹ 4.19B₹ 5.14B₹ 4.40B₹ 3.54B₹ 2.79B
₹ 2.93B₹ 6.02B₹ 5.21B₹ 5.18B₹ 4.16B
₹ 517.06M₹ -1.07B₹ -1.09B₹ -1.96B₹ -1.79B
₹ 3.45B₹ 4.95B₹ 4.13B₹ 3.22B₹ 2.38B
₹ 2.61B₹ 3.72B₹ 3.08B₹ 2.40B₹ 1.75B
Per Share Metrics
Basic EPS₹ 12.39₹ 17.76₹ 14.72₹ 11.47₹ 8.36
Diluted EPS₹ 12.39₹ 17.76₹ 14.72₹ 11.47₹ 8.36
Weighted Average Shares Outstanding210.58M209.23M209.23M209.23M209.23M
Weighted Average Shares Outstanding (Diluted)210.58M209.23M209.23M209.23M209.23M

Currency in INR

Concord Biotech Ltd. Earnings and Revenue History

05B10B15B16 %24 %32 %40 %EarningsProfit Margin2020202120222023202420252026RevenueEarningsProfit Margin